The Iberfar Group
FAI THERAPEUTICS, a new division of IBERFAR, specialises in medicinal cannabis, drawing on the expertise of Agrovete, IBERFAR and Ferraz Lynce.
With a vertically integrated process, it oversees all stages – from cultivation and extraction to production and distribution – ensuring the highest standards of quality and safety.
Focused on offering effective cannabis-based therapies, FAI Therapeutics combines established pharmaceutical expertise with the latest scientific advances to meet rigorous safety and quality standards.
IBERFAR, INDÚSTRIA FARMACÊUTICA, S.A., is the Group’s leading company. With a century of experience, it has developed expertise across all areas of the pharmaceutical industry. Its core activity is the contract manufacture of solid and liquid dosage medicines for third-party clients.
IBERFAR provides high-quality products with short delivery times, while maintaining the flexibility needed to meet the specific requirements of each client.
As a pharmaceutical manufacturer, it operates a modern, EU cGMP-certified production facility, conveniently located near Lisbon and only 20 minutes from major logistics hubs.
IBERFAR is authorised to manufacture non-sterile solid and liquid products, including psychotropic substances.
Agrovete started operating in 1962, becoming a reference in the sale and installation of livestock and agricultural equipment over the years.
Its longevity has enabled Agrovete to gain extensive experience in the agricultural and livestock sectors.
Since its foundation, it has been associated with various innovations. In 2010, Agrovete merged with Proselecte and Sulsem, strengthening its position in the seed sector.
At present, Agrovete is focused on the cultivation of medical cannabis.
